Takeda Pharmaceutical Co Ltd
XBER:TKD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Takeda Pharmaceutical Co Ltd
XBER:TKD
|
JP |
|
E
|
Eurobank Ergasias Services and Holdings SA
F:EFGD
|
GR |
|
DP Eurasia NV
LSE:DPEU
|
NL |
|
A
|
Avid Technology Inc
F:AVD
|
US |
Wall Street
Price Targets
TKD Price Targets Summary
Takeda Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for
TKD
is 26.33 EUR
with a low forecast of 21 EUR and a high forecast of 31.12 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is TKD's stock price target?
Price Target
26.33
EUR
According to Wall Street analysts, the average 1-year price target for
TKD
is 26.33 EUR
with a low forecast of 21 EUR and a high forecast of 31.12 EUR.
What is Takeda Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
1%
For the last 13 years the
compound annual growth rate for
Takeda Pharmaceutical Co Ltd's revenue is
9%.
The projected
CAGR
for the next 3 years is
1%.
What is Takeda Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
-5%
For the last 13 years the
compound annual growth rate for
Takeda Pharmaceutical Co Ltd's operating income is
6%.
The projected
CAGR
for the next 2 years is
-5%.
What is Takeda Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
46%
For the last 13 years the
compound annual growth rate for
Takeda Pharmaceutical Co Ltd's net income is
-1%.
The projected
CAGR
for the next 3 years is
46%.
